摘要
目的探讨低分子肝素钠联合地屈孕酮治疗先兆流产的临床疗效。方法选择我院2017年2月~2018年4月收治的先兆流产患者120例,随机分为对照组和观察组,每组60例。对照组采用地屈孕酮片治疗,观察组在对照组的基础上采用低分子肝素钠治疗,持续治疗2周后,比较两组的临床疗效。结果观察组有效率为95.00%(57/60),对照组为76.67%(46/60),差异有统计学意义(P<0.05);观察组血小板计数、纤维蛋白原及D-二聚体含量均低于对照组,差异有统计学意义(P<0.05)。结论采用低分子肝素钠联合地屈孕酮治疗先兆流产,能延长妊娠周期,缓解患者临床症状。
Objective:To investigate the clinical efficacy of low molecular weight heparin combined with dorsprone in treatment of threatened abortion.Methods:Totally,120 patients with threatened abortion were admitted and treated in our hospital from February 2017 to April 2018.They were randomly divided into test group and control group with 60 patients in each group.Patients in control group were treated with dorsprone,while patients in test group were treated with low molecular weight heparin combined with dorsprone.The treatment results was compared between the two groups for two weeks of continue treatment.Results:The effective rate of the test group was 95.00%(57/60),which was significant higher than the 76.67%(46/60)of the control group.The platelet counts,fibrinogen and D-dimer in the test group were significant lower than those in the control group(P<0.05).Conclusions:The treatment of threatened abortion with low molecular weight heparin combined with dorsprone can extend the pregnancy period and relief clinical symptoms.
作者
王江艳
Jiangyan Wang(Department of Obstetrics,Zhengzhou Santa Maria Matemity Hospital,Zhengzhou,Henan 450000,China)
出处
《西藏医药》
2021年第4期15-17,共3页
Tibetan Medicine
关键词
先兆流产
低分子肝素钠
地屈孕酮
Threatened Abortion
Low Molecular Weight Heparin
Dorsprone
